Loading…
argenx SE is projected to rise to $1,030.36 by 2027, a +26% move from its current price of $820.63. ARGX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $807.72 | $820.62 | $833.72 | 0.00% |
| May 30 | $802.43 | $820.60 | $839.19 | 0.00% |
| May 31 | $798.39 | $820.59 | $843.41 | 0.00% |
| Jun 1 | $794.99 | $820.58 | $846.99 | -0.01% |
| Jun 2 | $792.01 | $820.57 | $850.15 | -0.01% |
| Jun 3 | $789.33 | $820.55 | $853.01 | -0.01% |
| Jun 4 | $786.87 | $820.54 | $855.66 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $786.87 | $820.54 | $855.66 | -0.01% |
| Week 2 | $773.24 | $820.45 | $870.54 | -0.02% |
| Week 3 | $762.93 | $820.36 | $882.12 | -0.03% |
| Week 4 | $754.33 | $820.27 | $891.98 | -0.04% |
| Week 5 | $746.82 | $820.19 | $900.75 | -0.05% |
| Week 6 | $740.09 | $820.10 | $908.75 | -0.07% |
| Week 7 | $733.95 | $820.01 | $916.15 | -0.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
argenx SE is a commercial-stage biopharma company developing therapies for autoimmune diseases. The company offers VYVGART for the treatment of gMG and immune thrombocytopenia (ITP), and VYVGART HYTRULO for the treatment of gMG and CIDP.
In addition to these therapies, argenx is advancing efgartigimod for several conditions and developing a broader FcRn pipeline, with empasiprubart for MMN, delayed graft function, and CIDP; adimanebart for congenital myasthenic syndrome and spinal muscular atrophy. It has strategic partnerships and license agreements with Zai Lab, Halozyme Therapeutics, OncoVerity, Inc., and AbbVie, Inc.
argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
ARGX is currently priced at $806.67 per share and has a market capitalization of $50.41B, ranking 315 by market cap.
The stock shows bullish technical sentiment, with RSI14 at 50, the 50-day simple moving average at $769.98 and the 200-day simple moving average at $794.49.
Near-term technical levels include a support of $775.03 and a resistance of $849.04, with a 30-day price range from $723.30 to $899.63. The stock exhibits an annualized volatility of 40%.
Overall, the price outlook remains bullish over the multi-year horizon, supported by sizable forecast upside across the years.
A major floor 19.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.6% below — buyers have tended to step in here.
The nearest ceiling, 3.5% above — a clean break opens room to run.
A major ceiling 8.3% above — clearing it would confirm fresh momentum.
Key ARGX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARGX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $811.20 | Buy | $811.14 | Buy |
| MA 10 | $805.42 | Buy | $806.99 | Buy |
| MA 20 | $800.22 | Buy | $801.68 | Buy |
| MA 50 | $774.46 | Buy | $791.46 | Buy |
| MA 100 | $788.43 | Buy | $789.16 | Buy |
| MA 200 | $795.96 | Buy | $766.97 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.81 | Neutral |
| Stoch RSI (14) | 83.05 | Sell |
| CCI (20) | 110.49 | Buy |
| Williams %R (14) | -3.27 | Info |
| MACD (12,26,9) | 0.48 | Buy |
| ROC (12) | 4.92 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 96.73 | Sell |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | 7.66 | Buy |
| Ultimate (7,14,28) | 57.80 | Neutral |
| Momentum (10) | 7.82 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 816.26 | Buy |
| ADX (14) | 11.90 | Neutral |
| ATR (14) | 12.72 | Info |
The 30-day picture shows a low of $723.30 and a high of $899.63, illustrating a wide near-term trading range.
The near-term technical backdrop is bullish, with RSI around 50 and prices flirting with the nearby moving averages. Key reference levels are a support at $775.03 and a resistance at $849.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $663.93 | $820.63 | $1,070.35 | 0% | Neutral | |
| $841.73 | $1,030.36 | $1,320.20 | +26% | Bullish | |
| $951.23 | $1,185.65 | $1,558.86 | +44% | Bullish | |
| $1,172.85 | $1,484.03 | $1,991.76 | +81% | Bullish | |
| $1,334.62 | $1,711.21 | $2,337.32 | +109% | Bullish | |
| $1,339.79 | $1,738.59 | $2,411.71 | +112% | Bullish | |
| $1,472.97 | $1,932.82 | $2,718.84 | +136% | Bullish | |
| $1,598.42 | $2,119.37 | $3,019.44 | +158% | Bullish | |
| $1,770.12 | $2,370.22 | $3,416.82 | +189% | Bullish | |
| $2,141.16 | $2,894.03 | $4,217.98 | +253% | Bullish | |
| $2,788.18 | $3,929.91 | $6,000.61 | +379% | Bullish | |
| $5,637.51 | $8,520.62 | $13,942.03 | +938% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $663.93 | $820.63 | $962.92 | +0.00% |
| June 2026 | $713.68 | $832.54 | $990.04 | +1.45% |
| July 2026 | $698.44 | $819.47 | $983.72 | -1.57% |
| August 2026 | $700.01 | $825.00 | $997.57 | +0.68% |
| September 2026 | $719.84 | $851.53 | $1,035.76 | +3.22% |
| October 2026 | $721.89 | $856.87 | $1,047.87 | +0.63% |
| November 2026 | $713.83 | $849.84 | $1,044.17 | -0.82% |
| December 2026 | $726.40 | $867.28 | $1,070.35 | +2.05% |
Click any year to see its month-by-month ARGX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ARGX is projected to trade between $663.93 and $1,070.35, averaging $820.63 — a potential gain of 0% from today's $820.63. A consolidation phase looks the most probable path here.
argenx SE's 2027 outlook centres on $1,030.36, within a $841.73 to $1,320.20 range. That is up +26% on the projected 2026 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2028, ARGX could reach as high as $1,558.86, with a base case around $1,185.65 and support toward $951.23 — roughly +44% from $820.63. Buyers look set to stay in control over this stretch.
Expect ARGX to range from $1,172.85 to $1,991.76 through 2029. The $1,484.03 average target implies a +81% move from current prices. That is up +25% on the projected 2028 average. Momentum favours further upside here.
The ARGX price prediction for 2030 points to an average of $1,711.21 (low $1,334.62, high $2,337.32) — a potential gain of +109% on today's $820.63. Buyers look set to stay in control over this stretch.
In 2031, ARGX is projected to trade between $1,339.79 and $2,411.71, averaging $1,738.59 — a potential gain of +112% from today's $820.63. That is up +2% on the projected 2030 average. Momentum favours further upside here.
argenx SE's 2032 outlook centres on $1,932.82, within a $1,472.97 to $2,718.84 range. That is up +11% on the projected 2031 average. That marks a +136% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ARGX could reach as high as $3,019.44, with a base case around $2,119.37 and support toward $1,598.42 — roughly +158% from $820.63. Momentum favours further upside here.
Expect ARGX to range from $1,770.12 to $3,416.82 through 2034. The $2,370.22 average target implies a +189% move from current prices. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ARGX price prediction for 2035 points to an average of $2,894.03 (low $2,141.16, high $4,217.98) — a potential gain of +253% on today's $820.63. Momentum favours further upside here.
In 2040, ARGX is projected to trade between $2,788.18 and $6,000.61, averaging $3,929.91 — a potential gain of +379% from today's $820.63. That is up +36% on the projected 2035 average. Buyers look set to stay in control over this stretch.
argenx SE's 2050 outlook centres on $8,520.62, within a $5,637.51 to $13,942.03 range. That is up +117% on the projected 2040 average. That marks a +938% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ARGX today (≈ 1.218576 ARGX) could be worth
$10,383.02
+$9,383.02 (+938%) by 2050 · US Dollar
Based on the average projected ARGX price of $8,520.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARGXwould be worth at today's price.
$1,000 invested in ARGX on May 27, 2025 (≈ 1.724822 ARGX) would be worth
$1,415.44
+$415.44 (+41.5%) today · 1.42× · US Dollar
Based on a ARGX entry price of $579.77 vs. today's $820.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $804.25 | $1,020.37 | +2.0% |
| 1 month ago | $783.74 | $1,047.07 | +4.7% |
| 3 months ago | $771.53 | $1,063.64 | +6.4% |
| 6 months ago | $911.98 | $899.83 | -10.0% |
| 1 year ago | $579.77 | $1,415.44 | +41.5% |
| All time (5.0y) ago | $275.88 | $2,974.59 | +197.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARGX forecast.
Our base-case forecast reaches $1,600.00 around 2030.
Implied market cap at $1,600.00: $99.5B
The multi-year forecast paints a strong upside trajectory. In 2026 the average price is $806.67 with a min of $663.93 and a max of $1,071.47, corresponding to a 0% ROI and a neutral sentiment.
From there, the outlook accelerates: 2027 averages $1,036.54 (max $1,335.89, min $843.38; ROI 28.5%, bullish); 2028 averages $1,215.72 (max $1,609.67, min $970.43; ROI 50.7%, bullish); 2029 averages $1,536.85 (max $2,079.18, min $1,207.36; ROI 90.5%, bullish).
By 2030 the average is $1,773.38 (min $1,373.75, max $2,443.61; ROI 119.8%, bullish), and by 2031 the average is $1,814.42 (min $1,387.71, max $2,540.92; ROI 124.9%). The forecast extends to 2032 with an average of $2,046.41 (max $2,907.93) and 2033 at $2,255.25 (max $3,247.60), continuing higher through 2034 ($2,546.84) and 2035 ($3,133.35).
Looking further, 2040 shows an average of $4,331.88 (max $6,705.66, min $3,033.44; ROI 437%), and 2050 concludes with an average of $9,551.74 (max $15,889.46, min $6,205.88; ROI 1084.1%), with bullish sentiment throughout.
Tap a question to reveal the answer.
Average price $1,773.38; minimum $1,373.75; maximum $2,443.61; ROI 119.8%; sentiment BULLISH.
Forecasts show bullish momentum across multiple years, with 2027 average $1,036.54 and 2030 average $1,773.38; ROI reaches 119.8% by 2030 and 1084.1% by 2050. These are estimates and not guarantees.
Yes. The forecast shows a max price above $2,000, including $2,079.18 in 2029 and $2,443.61 in 2030.
Current price is $806.67 and market cap is $50.41B.
30-day range is $723.30 to $899.63; support is $775.03 and resistance is $849.04; RSI is 50 and sentiment is BULLISH.
argenx SE Community Discussion
0Share your argenx SE price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.